Results 81 to 90 of about 7,431 (174)

Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles [PDF]

, 2017
Marc Schweneker, Andrea Laimbacher, Gert Zimmer, Susanne Wagner, Elisabeth M. Schraner, Michael Wolferstätter, Marieken Klingenberg, Ulrike Dirmeier, Robin Steigerwald, Henning Lauterbach, Hubertus Hochrein, Paul Chaplin, Mark Suter, Jürgen Hausmann   +13 more
openalex   +1 more source

The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation

Frontiers in Immunology
IntroductionModified Vaccinia Virus Ankara (MVA) is a safe vaccine vector inducing long- lasting and potent immune responses. MVA-mediated CD8+T cell responses are optimally induced, if both, direct- and cross-presentation of viral or recombinant ...
Ylenia Longo, Sara Moreno Mascaraque, Giuseppe Andreacchio, Julia Werner, Ichiro Katahira, Elena De Marchi, Anna Pegoraro, Robert Jan Lebbink, Karl Köhrer, Patrick Petzsch, Ronny Tao, Francesco Di Virgilio, Elena Adinolfi, Ingo Drexler   +13 more
doaj   +1 more source

Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington. [PDF]

Open Forum Infect Dis, 2023
Ramchandani MS, Berzkalns A, Cannon CA, Dombrowski JC, Brown E, Chow EJ, Barash E, Pogosjans S, Smith D, Golden MR.   +9 more
europepmc   +1 more source

Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates [PDF]

Leonie Mayer, Leonie M. Weskamm, Marylyn M. Addo   +2 more
openalex   +1 more source

Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein [PDF]

, 2023
Matthijs P. Raadsen, Christine Dahlke, Anahita Fathi, Mart M. Lamers, Petra van den Doel, Luca M. Zaeck, Martin E. van Royen, Erwin de Bruin, Reina S. Sikkema, Marion Koopmans, Eric C. M. Van Gorp, Gerd Sutter, Rory D. de Vries, Marylyn M. Addo, Bart L. Haagmans   +14 more
openalex   +1 more source

Modified Vaccinia Virus Ankara Triggers Chemotaxis of Monocytes and Early Respiratory Immigration of Leukocytes by Induction of CCL2 Expression [PDF]

, 2009
Michael H. Lehmann, Wolfgang Kastenmüller, Judith D. Kandemir, Florian Brandt, Yasemin Suezer, Gerd Sutter   +5 more
openalex   +1 more source

Clinical characteristics of mpox infection in individuals who received a first dose of modified vaccinia Ankara immunisation. [PDF]

Sex Transm Infect, 2023
Agunbiade S, Burton F, Muirhead J, Whitlock GG, Girometti N.   +4 more
europepmc   +1 more source

Immunomonitoring technologies for the evaluation of Modified Vaccinia Virus Ankara expressing HIV-1 nef as a vaccine against AIDS [PDF]

, 2010
Sarah Kutscher
openalex   +1 more source

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial [PDF]

, 2018
Rory D. de Vries, Arwen F. Altenburg, Nella J. Nieuwkoop, Erwin de Bruin, Stella E. van Trierum, Mark Pronk, Mart M. Lamers, Mathilde Richard, David F. Nieuwenhuijse, Marion Koopmans, Joost H. C. M. Kreijtz, Ron A. M. Fouchier, Albert D. M. E. Osterhaus, Gerd Sutter, Guus F. Rimmelzwaan   +14 more
openalex   +1 more source

The production of recombinant platelet-derived growth factor D using the second generation modified vaccinia Ankara viral system. [PDF]

Protein Sci, 2022
Najy AJ, Pham T, Pradeau-Aubreton K, Drillien R, Kim HC.   +4 more
europepmc   +1 more source